Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.39 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.39 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.39 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.39 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.36 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.36 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.36 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.36 |
| ▸ | PYGB | P11216 | 5/20 | 0.36 |
| ▸ | PYGL | P06737 | 3/20 | 0.36 |
| ▸ | PYGM | P11217 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6002015 | 0.88 | SLC28A1 (0.50) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL12658269 | 0.88 | SLC28A1 (0.50) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL42133 | 0.88 | SLC28A1 (0.50) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| Hydrogen Sulfide SCHEMBL28043850 | 0.87 | SLC28A1 (0.49) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| Ammonia Solution, Strong SCHEMBL28145131 | 0.87 | SLC28A1 (0.49) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL31439434 | 0.84 | P2RY6 (0.39) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| Phosphoric Acid SCHEMBL18486662 | 0.84 | SLC28A1 (0.46) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| Phosphoric Acid SCHEMBL18486628 | 0.84 | SLC28A1 (0.46) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL6028061 | 0.84 | SLC28A1 (0.42) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL29186646 | 0.83 | PYGM (0.48) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060818-A | Chemically modified circular RNA molecules, methods of making and uses thereof | 上海元码智药生物技术有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-119842712-A | 3' UTR for improving mRNA translation efficiency and application thereof | 北京臻知医学科技有限责任公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-119013398-A | Novel method for producing polynucleotides comprising oligonucleotides | 葛兰素史密斯克莱知识产权发展有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-112236438-B | Phosphorus (V) based reagent, method for the production thereof, and use thereof for producing stereoregular organic phosphorus (V) compounds | 百时美施贵宝公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-114127285-B | Methods and compositions for editing nucleotide sequences | 布罗德研究所股份有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-112996854-B | High purity PEG lipids and uses thereof | 摩登纳特斯有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-118076631-A | Modeling antibody responses to antigens using antibodies | 瑞泽恩制药公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-118043306-A | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-114391008-B | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117440824-A | RNA vaccine against SARS-CoV-2 variants | 库瑞瓦格欧洲公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-117222422-A | Sanopassing polypeptides and their use in the treatment of cancer | 旗舰创业创新五公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-116814614-A | UTR sequence | 埃泽瑞斯公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-116726203-A | Combination of MRNA encoding immunomodulatory polypeptides and uses thereof | 莫得纳特斯公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-116685682-A | Guided editing guide RNAs, compositions thereof, and methods of using the same | 布罗德研究所股份有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-109154001-B | UTR sequence | 埃泽瑞斯公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-109476718-B | Combination of MRNA encoding immunomodulatory polypeptides and uses thereof | 莫得纳特斯公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-116096873-A | Methods and compositions for editing two strands of a target double-stranded nucleotide sequence simultaneously | 布罗德研究所股份有限公司 | 2023-05-09 | — | — | CN | disclosed |